Structural Heart Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 8.56 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Structural Heart Devices Market Analysis
The Structural Heart Devices Market is poised to grow at a CAGR of 8.56% over the forecast period (2022 - 2027).
The Covid-19 pandemic affected healthcare systems globally and resulted in the interruption of usual care in many healthcare facilities. This exposed vulnerable patients with cardiovascular diseases to significant risks. However, the demand for various cardiovascular devices including structural heart devices increased during the pandemic, owing to the increased risk of infection among cardiovascular patients. Several research also suggested the efficiency of the drugs among Covid-19 infected patients. For instance, the article 'Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin' published in January 2021 showed that when a case study was conducted on a Chinese male of 37 years admitted to hospital with chest pain and dyspnoea for 3 days, accompanied by diarrhea, the patient chest computed tomography (CT) examination indicated pulmonary infection, enlarged heart, and pleural effusion, while the electrocardiogram (ECG) suspected ST-segment elevation acute myocardial infarction, which led to a better diagnosis of the patient. Such research during the pandemic is anticipated to generate demand for structural heart devices, used for patient survival. Thus, the pandemic is anticipated to show a considerable impact on the market studied.
Factors such as increasing cardiovascular diseases, rapid technological advances, growing public awareness, and government initiatives related to cardiovascular diseases globally are expected to positively impact the market growth.
The rising prevalence of cardiovascular diseases (CVDs) globally, growing research and development (R&D) and investments in efficient drug development, and increasing availability of reimbursement policies are the major factors that contribute to the market growth. For instance, the 'UK Factsheet January 2022' published by 'British Heart Foundation (BHF)' shows that around 7.6 million people are living with heart and circulatory diseases in the United Kingdom. Additionally, as per the source above, nearly 4 million males and 3.6 million females were diagnosed with heart and circulatory diseases in the country in 2021. This high prevalent heart and circulatory disease patients generate demand for more treatment procedures such as angioplasty and heart surgeries for patient survival. Thereby creating opportunities for structural devices such as heart valves, and annuloplasty rings globally. Therefore, the burden of heart diseases across the globe is expected to fuel the market growth during the analysis period.
Furthermore, the development activities by the market players in the form of product launches, acquisitions, mergers, and investments are also expected to enhance the market growth. For instance, in August 2021, CORCYM enrolled the first patient in MANTRA (Mitral, Aortic aNd Tricuspid post-maRket Study in a reAl-world setting) study. The first patient was implanted in Italy, at Citta di Lecce Hospital with a Bicarbon aortic mechanical valve. Such advancements are expected to drive the market to grow in the future.
Therefore, owing to the above-mentioned factors the market studied is expected to grow over the forecast period. However, less accessibility to new technology in the emerging markets and irregular reimbursement scenarios are the factors that are anticipated to hinder the market growth.
Structural Heart Devices Market Trends
This section covers the major market trends shaping the Structural Heart Devices Market according to our research experts:
Heart Valve Devices Segment is Expected to Grow Over the Forecast Period
Heart devices include heart valve balloon occluders and annuloplasty rings. If the heart is oversized or has a leaky valve, these devices are utilized to restructure and tighten the ring around the heart. Owing to the increasing cardiovascular diseases globally, the demand for heart valve devices is growing, which is further expected to fuel market growth.
The article published in June 2022 stated that heart valve surgery is a procedure to treat heart valve disease which involves at least one of the four heart valves not working properly. Heart valves keep blood flowing in the correct direction through the heart. Thus, the advantages of the devices are anticipated to fuel the segment growth.
Additionally, product approvals and new drug launches are the primary factors affecting the availability of a huge concentration of drugs in the market. This is expected to drive segment growth. For instance, in September 2021, Abbott received the Food and Drug Administration (FDA) approval for the company's Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform.
In addition, in August 2021, the First 'Made in India' 3-D printed heart valve was developed in Chennai. The new heart valves are developed using 3D printers which can overcome the problems related to artificial heart valves. Thus, increasing developments are anticipated to drive segment growth over the forecast period.
Therefore, owing to the factors mentioned above, the segment is anticipated to witness growth over the analysis period.
North America is Expected to Hold Largest Market Share over the Forecast Period
North America is anticipated to witness growth over the forecast period and dominate the market. Among other countries in the region, the United States is leading the market, due to factors such as an increase in healthcare expenditure, increasing research and developments, and a rising prevalence of heart diseases. Additionally, the rising geriatric population across the United States is the primary driver for the United States structural heart devices market.
The data updated by Cedars-Sinai in January 2022 shows that coronary artery bypass graft surgery (CABG), also known as coronary artery bypass, or bypass surgery, is the most common type of heart surgery and more than 300,000 people have successful bypass surgery in the United States each year. This shows a rising burden of cardiovascular diseases in the country.
In addition, the Centers for Disease Control and Prevention (CDC) data updated in July 2022 shows that coronary heart disease is the most common type of heart disease, and approximately 20.1 million adults of age 20 and older have the disease in the United States. Additionally, as per the CDC data every 40 seconds, someone suffers from a heart attack and nearly 805,000 people in the United States have a heart attack every year. Thus, the high burden of cardiovascular diseases demands for the development of structural heart devices used for treatment in the United States. This is expected to fuel market growth.
Moreover, the development activities by the market players in the form of product launches, acquisitions, mergers, and investments are also expected to enhance the market growth. For example, in May 2022, Centerline Biomedical, Inc. completed the second in a series of structural heart navigation animal studies. Physicians from Cleveland Clinic's Heart, Vascular and Thoracic Institute evaluated the feasibility of applying the company's augmented reality image guidance technology to navigate structures in a beating heart. Thus, increasing developments are anticipated to drive market growth over the forecast period in the country.
Therefore, owing to the factors mentioned above, the market studied is anticipated to witness growth in the region.
Structural Heart Devices Industry Overview
The market is competitive with signicant contribution of several public and private companies operating at the global level. Many companies are now exploring collabroation opportunities in many of medical tourism destinations across the emerging markets of the world. Some of the top players include Abbott Laboratories, Boston Scientific Coporation, Medtronic PLC, Lepu Medical, and Edwards Life Sciences Corporation, among others.
Structural Heart Devices Market Leaders
Abbott Laboratories
Boston Scientific Corporation
Edwards Lifesciences Corporation
Medtronic
Lepu Medical Technology(Beijing)Co.,Ltd.
*Disclaimer: Major Players sorted in no particular order
Structural Heart Devices Market News
- In May 2022, Philips launched EchoNavigator 4.0, the new release of its image-guided therapy solution for the treatment of structural heart disease. EchoNavigator 4.0 gives users of Philips' EPIQ CVXi interventional cardiology ultrasound system a control of live fusion-imaging on the company's Image Guided Therapy System called 'Azurion - platform'.
- In February 2022, Genesis MedTech Group (Genesis or Group) completed the acquisition of JC Medical (JCM), a structural heart company that is primarily engaged in the design and development of transcatheter valve replacement products for the minimally invasive treatment of structural heart diseases. J-Valve, developed by JCM, is the first and only in China, to successfully develop and commercialize a minimally invasive TAVR device approved for both aortic regurgitation and stenosis patients.
Structural Heart Devices Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Cardiovascular Diseases
4.2.2 Technological Advancement in Medical Devices
4.2.3 Growing Participation of Government and Private Sector
4.3 Market Restraints
4.3.1 Less Accessibility to New Technology in the Emerging Markets
4.3.2 Irregular Reimbursement Scenario
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
5.1 By Product
5.1.1 Heart Valve Devices
5.1.2 Occluders & Delivery Systems
5.1.3 Annuloplasty Rings
5.1.4 Other Products
5.2 By Procedure
5.2.1 Replacement Procedures
5.2.2 Repair Procedures
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 France
5.3.2.2 Germany
5.3.2.3 United Kingdom
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Biomerics, LLC
6.1.3 Boston Scientific Corporation
6.1.4 Braile Biomedica
6.1.5 Comed B.V.
6.1.6 Edwards Lifesciences Corporation
6.1.7 JenaValve Technology, Inc.
6.1.8 Lepu Medical Technology(Beijing)Co.,Ltd.
6.1.9 LivaNova PLC
6.1.10 Medtronic
6.1.11 Cryolife Inc.
6.1.12 AtriCure, Inc.
6.1.13 NuMed Inc.
6.1.14 Venus Medtech (Hangzhou) Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Structural Heart Devices Industry Segmentation
As per the scope of this report, structural heart disease is a non-coronary defect of the heart, thus not affecting the blood vessels in the heart. Most of the structural heart conditions are present since birth (congenital), but these can also be acquired later in life, owing to wear & tear from infection. Advancements in the medical field have replaced open heart surgical procedures with minimally invasive procedures. The Structural Heart Devices Market is segmented by Product (Heart Valve Devices, Occluders & Delivery Systems, Annuloplasty Rings and Other Products), Procedure (Replacement Procedures and Repair Procedures), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product | |
| Heart Valve Devices | |
| Occluders & Delivery Systems | |
| Annuloplasty Rings | |
| Other Products |
| By Procedure | |
| Replacement Procedures | |
| Repair Procedures |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Structural Heart Devices Market Research FAQs
What is the current Global Structural Heart Devices Market size?
The Global Structural Heart Devices Market is projected to register a CAGR of 8.56% during the forecast period (2024-2029)
Who are the key players in Global Structural Heart Devices Market?
Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic and Lepu Medical Technology(Beijing)Co.,Ltd. are the major companies operating in the Global Structural Heart Devices Market.
Which is the fastest growing region in Global Structural Heart Devices Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Structural Heart Devices Market?
In 2024, the North America accounts for the largest market share in Global Structural Heart Devices Market.
What years does this Global Structural Heart Devices Market cover?
The report covers the Global Structural Heart Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Structural Heart Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Structural Heart Devices Industry Report
Statistics for the 2024 Structural Heart Devices market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Structural Heart Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
